A
$ Value
$0
Shares
3,729
Price
$0
Filed
Feb 20
Insider
Name
PYOTT DAVID E I
Title
—
CIK
0001051578
Roles
Director
Transaction Details
Transaction Date
2026-02-18
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
3,729
Footnotes
The option shares will vest in three equal annual installments on February 18th of each of 2027, 2028, and 2029, subject to the Reporting Person's continuous service. | Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. | The RSUs will vest in three equal annual installments on March 15th of each of 2027, 2028, and 2029, subject to the Reporting Person's continuous service.
Filing Info
PYOTT DAVID E I's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-18 | TARS | A | $0 |
| 2026-02-18 | TARS | A | $0 |
| 2025-06-05 | PLRX | A | $0 |
| 2025-05-08 | ALNY | A | $0 |
| 2025-05-08 | ALNY | A | $0 |
Other Insiders at TARS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| PYOTT DAVID E I | — | — | 2026-02-18 |
|
Farrow Jeffrey S
See Remarks
|
— | — | 2026-03-05 |
|
Mottiwala Aziz
Chief Commercial Officer
|
— | — | 2026-03-05 |
|
Neervannan Seshadri
Chief Operating Officer
|
— | $841K | 2026-03-20 |
|
Azamian Bobak R.
President/CEO and Board Chair
|
— | — | 2026-03-05 |
|
Whitfield Dianne C.
Chief Human Resources Officer
|
— | — | 2026-03-05 |
|
Wahl Bryan
General Counsel
|
— | — | 2026-03-05 |
|
Lin Elizabeth Yeu
Chief Medical Officer
|
— | — | 2026-03-05 |